Look for any podcast host, guest or anyone
Showing episodes and shows of

MeiLan K. Han, MD, MS

Shows

Living With Cystic FibrosisLiving With Cystic FibrosisHow to provide lung health everydaySubstack is where I discovered Dr. MeiLan Han! I was browsing through and was pleasantly surprised to read an article, and learn that she wrote a book called, Breathing Lessons. And to top it off, she’s from my home state of Michigan. I also learned the Dr. Han’s book was “a passion project during the pandemic.”I’m delighted to share a conversation with Dr. MeiLan Han, one of the country’s most respected voices in lung health and a tireless advocate for people living with chronic respiratory conditions.Dr. Han is a Professor of...2025-06-3040 minLeo RadioLeo RadioAIRE FRESCO | 20250422 | Juan Bautista Samper y Francisco Galiana, Miguel San Martín, Pedro Riba, Joaquín Huete, María meilán y Heriberto Morales, en el AIRE FRESCO de hoy martes 22 de abrilEra el día del Papa Francisco y así es como hemos realizado el programa. Pero también es mañana el día del libro y también hemos querido rendirle nuestro pequeño homenaje. Y por medio, algo de actualidad y un esbozo de lo que en breve será el congreso sobre espiritualidad que se celebrará en esta comarca. En conclusión, un programa muy completo que a nosotros, los que lo realizamos, nos ha encantado, esperando que a ti te haya sorprendido de igual manera.Una editorial extensa dedicada a la figura del recién...2025-04-221h 59Aire FrescoAire FrescoJuan Bautista y Francisco Galiana, Miguel San Martín, Pedro Riba, Joaquín Huete, María meilán ,hoy martes 22 de abrilEra el día del Papa Francisco y así es como hemos realizado el programa. Pero también es mañana el día del libro y también hemos querido rendirle nuestro pequeño homenaje. Y por medio, algo de actualidad y un esbozo de lo que en breve será el congreso sobre espiritualidad que se celebrará en esta comarca. En conclusión, un programa muy completo que a nosotros, los que lo realizamos, nos ha encantado, esperando que a ti te haya sorprendido de igual manera. Una editorial extensa dedicada a la figura del recién desaparecido Jorge Bergoglio...2025-04-222h 00PeerView Family Medicine & General Practice CME/CNE/CPE Video PodcastPeerView Family Medicine & General Practice CME/CNE/CPE Video PodcastMeiLan K. Han, MD, MS - Expert Insights on the Use of Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation: Taking It on a Case-by-Case BasisThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/TTR865. CME/MOC/AAPA credit will be available until March 10, 2026.Expert Insights on the Use of Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation: Taking It on a Case-by-Case Basis In support of improving...2025-03-2532 minPeerView Clinical Pharmacology CME/CNE/CPE VideoPeerView Clinical Pharmacology CME/CNE/CPE VideoMeiLan K. Han, MD, MS - Expert Insights on the Use of Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation: Taking It on a Case-by-Case BasisThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/TTR865. CME/MOC/AAPA credit will be available until March 10, 2026.Expert Insights on the Use of Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation: Taking It on a Case-by-Case Basis In support of improving...2025-03-2532 minPeerView Family Medicine & General Practice CME/CNE/CPE Audio PodcastPeerView Family Medicine & General Practice CME/CNE/CPE Audio PodcastMeiLan K. Han, MD, MS - Expert Insights on the Use of Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation: Taking It on a Case-by-Case BasisThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/TTR865. CME/MOC/AAPA credit will be available until March 10, 2026.Expert Insights on the Use of Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation: Taking It on a Case-by-Case Basis In support of improving...2025-03-2532 minPeerView Heart, Lung & Blood CME/CNE/CPE Audio PodcastPeerView Heart, Lung & Blood CME/CNE/CPE Audio PodcastMeiLan K. Han, MD, MS - Expert Insights on the Use of Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation: Taking It on a Case-by-Case BasisThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/TTR865. CME/MOC/AAPA credit will be available until March 10, 2026.Expert Insights on the Use of Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation: Taking It on a Case-by-Case Basis In support of improving...2025-03-2532 minPeerView Heart, Lung & Blood CME/CNE/CPE Video PodcastPeerView Heart, Lung & Blood CME/CNE/CPE Video PodcastMeiLan K. Han, MD, MS - Expert Insights on the Use of Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation: Taking It on a Case-by-Case BasisThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/TTR865. CME/MOC/AAPA credit will be available until March 10, 2026.Expert Insights on the Use of Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation: Taking It on a Case-by-Case Basis In support of improving...2025-03-2532 minPeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastPeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastMeiLan K. Han, MD, MS - Expert Insights on the Use of Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation: Taking It on a Case-by-Case BasisThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/TTR865. CME/MOC/AAPA credit will be available until March 10, 2026.Expert Insights on the Use of Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation: Taking It on a Case-by-Case Basis In support of improving...2025-03-2532 minCMECMEGoing Beyond Today’s Assessments to Confirm COPD, Are Biomarkers Key? Guest: Surya Bhatt, MD Host: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCMECMEInsights to Pharmaceutical Approaches in COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCMECMEDiagnosing COPD: From Symptoms to Assessment & the 2024 GOLD Standards Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCMECMEMolecular Mechanisms of COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCMECMEBreathing Through the Burden of COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minPulmonary MedicinePulmonary MedicineGoing Beyond Today’s Assessments to Confirm COPD, Are Biomarkers Key? Guest: Surya Bhatt, MD Host: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minPulmonary MedicinePulmonary MedicineInsights to Pharmaceutical Approaches in COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minPulmonary MedicinePulmonary MedicineBreathing Through the Burden of COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minPulmonary MedicinePulmonary MedicineMolecular Mechanisms of COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minPulmonary MedicinePulmonary MedicinePutting Theory Into Practice: Mastering Management of COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCMECMEMolecular Mechanisms of COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minPulmonary MedicinePulmonary MedicineMolecular Mechanisms of COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCME/CECME/CEPutting Theory Into Practice: Mastering Management of COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCME/CECME/CEInsights to Pharmaceutical Approaches in COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCME/CECME/CEGoing Beyond Today’s Assessments to Confirm COPD, Are Biomarkers Key? Guest: Surya Bhatt, MD Host: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCME/CECME/CEDiagnosing COPD: From Symptoms to Assessment & the 2024 GOLD Standards Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCME/CECME/CEMolecular Mechanisms of COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCME/CECME/CEBreathing Through the Burden of COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minPulmonary MedicinePulmonary MedicinePutting Theory Into Practice: Mastering Management of COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minPulmonary MedicinePulmonary MedicineInsights to Pharmaceutical Approaches in COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minPulmonary MedicinePulmonary MedicineGoing Beyond Today’s Assessments to Confirm COPD, Are Biomarkers Key? Guest: Surya Bhatt, MD Host: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCMECMEBreathing Through the Burden of COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minPulmonary MedicinePulmonary MedicineBreathing Through the Burden of COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCME/CECME/CEInsights to Pharmaceutical Approaches in COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCME/CECME/CEBreathing Through the Burden of COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCME/CECME/CEMolecular Mechanisms of COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCME/CECME/CEGoing Beyond Today’s Assessments to Confirm COPD, Are Biomarkers Key? Guest: Surya Bhatt, MD Host: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCME/CECME/CEDiagnosing COPD: From Symptoms to Assessment & the 2024 GOLD Standards Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCME/CECME/CEPutting Theory Into Practice: Mastering Management of COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCMECMEPutting Theory Into Practice: Mastering Management of COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCMECMEInsights to Pharmaceutical Approaches in COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCMECMEGoing Beyond Today’s Assessments to Confirm COPD, Are Biomarkers Key? Guest: Surya Bhatt, MD Host: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCMECMEPutting Theory Into Practice: Mastering Management of COPD Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minCMECMEDiagnosing COPD: From Symptoms to Assessment & the 2024 GOLD Standards Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach. 2024-10-1800 minLifeMinute Health & WellnessLifeMinute Health & WellnessFirst of its Kind Medicine Approved for A Chronic Lung DiseaseWatch the video: https://lifeminute.tv/health/video/first-its-kind-medicine-approved-chronic-lung-disease In the United States, more than 10 million people over the age of 40 live with chronic obstructive pulmonary disease (COPD), a chronic lung disease that limits air flow and causes breathing-related symptoms. COPD primarily affects people aged 40 and older, with current and former smokers having a higher risk of developing the disease. Patients with COPD have various symptoms that impact their daily life, including persistent cough and breathlessness. Those living with the disease often experience exacerbations, or flare ups, of their symptoms which may reduce lung function and...2024-10-1102 minLifeMinute Podcast: Health and WellnessLifeMinute Podcast: Health and WellnessFirst of its Kind Medicine Approved for A Chronic Lung DiseaseDr. MeiLan Han discusses the impact inadequately controlled COPD has on daily life and a new breakthrough treatment2024-10-1002 minATS Breathe EasyATS Breathe EasyFrom the Trenches: Episode 6 – MeiLan Han, MD, MSDr. Naftali Kaminski chats with Dr. MeiLan Han as she shares her journey into becoming Chief of Division of Pulmonary Critical Care at University of Michigan, starting off at a Veterinary facility in her first year of medical school and her non-linear career path; shares some advice in staying the course even if it isn’t the traditional route. 2024-04-3037 minwise athletes podcastwise athletes podcastOptimizing Lung Health | MeiLan K. Han MDFullscript for WiseAthletes Breathing is the essence of life. Yet lung function declines as we age. The chemicals and small particles breathed into our lungs leave a mark and reduce lung function, a little here and a little there. But we can slow the decline, and we can even recover lost function with targeted effort. Do you know how to protect and strengthen your lungs? Today I am joined by MeiLan K. Han, MD, a pulmonologist and the Chief of Pulmonary and Critical Care at the University of Michigan, and a national spokesperson for the...2024-04-0554 minwise athletes podcastwise athletes podcast#130 | Protecting Lung Health | MeiLan K. Han MDFullscript for WiseAthletes Breathing is the essence of life. Yet lung function declines as we age. The chemicals and small particles breathed into our lungs leave a mark and reduce lung function, a little here and a little there. But we can slow the decline, and we can even recover lost function with targeted effort. Do you know how to protect and strengthen your lungs? Today I am joined by MeiLan K. Han, MD, a pulmonologist and the Chief of Pulmonary and Critical Care at the University of Michigan, and a national spokesperson for the...2024-04-0554 minwise athleteswise athletesOptimizing Lung Health | MeiLan K. Han MDFullscript for WiseAthletes Breathing is the essence of life. Yet lung function declines as we age. The chemicals and small particles breathed into our lungs leave a mark and reduce lung function, a little here and a little there. But we can slow the decline, and we can even recover lost function with targeted effort. Do you know how to protect and strengthen your lungs? Today I am joined by MeiLan K. Han, MD, a pulmonologist and the Chief of Pulmonary and Critical Care at the University of Michigan, and a national spokesperson for the...2024-04-0554 minYe Olde CrimeYe Olde CrimeWarrior Women of Dahomey: Africa’s Fierce FightersLindsay and Madison discuss the Dahomey Amazons, as well as how history can be both good and bad, that women are badass, and how colonialism ruins everything. The fourth in our Black History Month series.Information pulled from the following sources: 2022 Atlas Obscura article by Line Sidonie Talla Mafotsing 2022 Insider article by Yoonji Han 2022 National Geographic article by Rachel Jones 2022 Smithsonian Magazine article by Meilan Solly 2020 The Best of Africa article by Veronica Mwanza 2020 Guardian Life article by Michael Bamidele 2018 BBC Travel article by Fleur Macdonald 1993 Paideuma article by Robin Law AAREG article UNESCO Women in...2023-02-2243 minJane Wilkens Michael Better Than BeforeJane Wilkens Michael Better Than BeforeBTB: Jane Wilkens Michael: Doctors' OrdersFeeling Better Than Before – Today Jane speaks with two renowned doctors, highly respected in their fields of mental health and pulmonary disease. Her first guest is noted psychiatrist, Dr Ken Duckworth, Chief Medical Officer of the National Alliance on Mental Illness, and co-author of You Are Not Alone: The NAMI Guide to Navigating Mental Health—With Advice from Experts and Wisdom from Real People and Families. Then Jane talks to Dr. MeiLan Han, a professor of Medicine in the Division of Pulmonary and Critical Care, University of Michigan, and author of Breathing Lessons: A Doctor’s Guide to Lung Health. For hi...2023-02-1638 minHealth Professional Radio - PodcastHealth Professional Radio - PodcastThis Lung Disease is Actually the 4th Leading Cause of Death in the U.S.Dr. MeiLan Han, MD, MS, Professor of Medicine and Chief of the Division of Pulmonary and Critical Care at the University of Michigan discusses chronic obstructive pulmonary disease (COPD), the importance of correctly identifying COPD risk, symptoms and exacerbations, knowing what to ask your doctor to make for a productive conversation and prioritizing treatment. She is joined by Tracy, a patient living with COPD who shares her journey and what she wished she knew before her COPD diagnosis. They talk about why websites like ListentoYourLungs.com and SpeakUpforCOPD.com can help patients prevent and manage flare-ups and the MY...2023-01-2311 minPodcasts360Podcasts360Biomarkers, Early Disease Pathogenesis of Lung Disease: Critical Observations, Ep. 8In this episode, Albert Rizzo, MD, interviews MeiLan Han, MD, MS, about chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, asthma, and pulmonary fibrosis, including an overview of recent cohort studies investigating important biomarkers of COPD, early disease pathogenesis, the future of therapies, and identifying patients for spirometry.2022-11-1533 minColumbus PerspectiveColumbus PerspectiveColumbus Perspective: October 16, 202200:00 Show Open / Toby Rice, President & CEO of EQT, a natural gas producer based in Pittsburgh, discusses high energy costs and supply issues. 15:30 Dr. Meilan Han, a pulmonologist and critical care specialist in Michigan, talks about whooping cough and the vaccine available to prevent it. 26:00 Courtesy of our sister station, WBNS 10-TV, Tracy Townsend presents information about the battle over abortion rights in Ohio; the upcoming election; and a program in Franklin County called "Move to Prosper" that offers rental assistance. 52:00 Dr. Julie Panepinto, Acting Director for the Division of Blood Diseases and Resources within the National Heart, Lung and Blood...2022-10-1659 minPri-Med PodcastsPri-Med PodcastsCOPD Treatment for Primary Care ProvidersCredits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/copd-treatment-for-primary-care-providers Overview: “Lung Health Updates for Primary Care Providers: Conversations with NHLBI” is a series of CME podcast episodes produced by Pri-Med in partnership with Learn More Breathe Better®, a program of the National Heart, Lung, and Blood Institute of the National Institutes of Health. In this episode on COPD treatment for primary care providers, we are joined by Dr. Mihaela Stefan, a Program Officer with NHLBI’s Division of Lung Diseases, and Dr. MeiLan Han, Professor of Medicine...2022-10-1118 minThe Proof with Simon HillThe Proof with Simon HillA doctor’s guide to lung health | Dr MeiLan HanIn Episode #220, Dr MeiLan Han joins me to discuss the lungs and respiratory system.Despite being an incredibly important factor of our overall health, the respiratory system is often overlooked. Most people’s knowledge is surface level, and we aren’t educated on the importance of the lungs or how to best support respiratory health. Dr MeiLan Han joins me in this episode to explain what the respiratory system is, how it works, and what we can do to optimise it.In this episode, Dr Han establishes what the respiratory system is and how it work...2022-08-081h 36The Proof with Simon HillThe Proof with Simon HillA doctor’s guide to lung health | Dr MeiLan HanIn Episode #220, Dr MeiLan Han joins me to discuss the lungs and respiratory system.Despite being an incredibly important factor of our overall health, the respiratory system is often overlooked. Most people’s knowledge is surface level, and we aren’t educated on the importance of the lungs or how to best support respiratory health. Dr MeiLan Han joins me in this episode to explain what the respiratory system is, how it works, and what we can do to optimise it.In this episode, Dr Han establishes what the respiratory system is and how it work...2022-08-081h 36The Home Health Care Today ShowThe Home Health Care Today ShowSeason 2: Episode 11: Healthy Lungs going into the Summer Months - MeiLan Han, MD., MS. University of MichiganDr. MeiLan Han, MD, MS.. MS, is a Professor of Medicine and Chief of the Division of Pulmonary and Critical Care at the University of Michigan.  Dr. Han is also  the author of Breathing Lessons: A Doctor's Guide to Lung Health. Dr. Han explains the importance of lung health for people of all ages. During this episode she spends time discussing COPD, Asthma, COVID 19, and other lung health issues.  "Dr. Han’s research has focused on defining phenotypes in COPD using imaging. She is a lead investigator for several NIH sponsored COPD studies. She also serve...2022-07-0137 minThe Home Health Care Today ShowThe Home Health Care Today ShowSeason 2: Episode 11: Healthy Lungs going into the Summer Months - MeiLan Han, MD., MS. University of MichiganDr. MeiLan Han, MD, MS.. MS, is a Professor of Medicine and Chief of the Division of Pulmonary and Critical Care at the University of Michigan.  Dr. Han is also  the author of Breathing Lessons: A Doctor's Guide to Lung Health.Dr. Han explains the importance of lung health for people of all ages. During this episode she spends time discussing COPD, Asthma, COVID 19, and other lung health issues. "Dr. Han’s research has focused on defining phenotypes in COPD using imaging. She is a lead investigator for several NIH sponsored COPD studies. She also serve...2022-06-3037 minThe Home Health Care Today ShowThe Home Health Care Today ShowSeason 2: Episode 11: Healthy Lungs going into the Summer Months - MeiLan Han, MD., MS. University of MichiganDr. MeiLan Han, MD, MS.. MS, is a Professor of Medicine and Chief of the Division of Pulmonary and Critical Care at the University of Michigan.  Dr. Han is also  the author of Breathing Lessons: A Doctor's Guide to Lung Health. Dr. Han explains the importance of lung health for people of all ages. During this episode she spends time discussing COPD, Asthma, COVID 19, and other lung health issues.  "Dr. Han’s research has focused on defining phenotypes in COPD using imaging. She is a lead investigator for several NIH sponsored COPD studies. She also serve...2022-06-1208 minThe Home Health Care Today ShowThe Home Health Care Today ShowSeason 2: Episode 11: Healthy Lungs going into the Summer Months - MeiLan Han, MD., MS. University of MichiganDr. MeiLan Han, MD, MS.. MS, is a Professor of Medicine and Chief of the Division of Pulmonary and Critical Care at the University of Michigan.  Dr. Han is also  the author of Breathing Lessons: A Doctor's Guide to Lung Health.Dr. Han explains the importance of lung health for people of all ages. During this episode she spends time discussing COPD, Asthma, COVID 19, and other lung health issues. "Dr. Han’s research has focused on defining phenotypes in COPD using imaging. She is a lead investigator for several NIH sponsored COPD studies. She also serve...2022-06-1208 minHealthcare AmericanaHealthcare Americana10 Questions We Need To Ask Ourselves About Lung HealthOne of America's most prominent pulmonologists; Professor of medicine and chief of pulmonary and critical care at the University of Michigan, a spokesperson for the American Lung Association and the author of Breathing Lessons: A Doctor's Guide to Lung Health. Meilan K. Han discusses the need to have lung health as more of a focal point topic in the doctor’s office. TwitterInstagramLinkedInMore on Freedom HealthworksMore on Meilan K. HanSubscribe at https://healthcareamericana.com/episodes/2022-06-0932 minThis Generation with Dr Sam HazledineThis Generation with Dr Sam HazledineDr MeiLan Han on the gift of informationDr MeiLan Han, MD MS, is a Professor of Medicine and Chief of the Division of Pulmonary and Critical Care at the University of Michigan. in 2021, she published Breathing Lessons: A Doctors Guide to Lung Health. Dr Sam Hazledine caught up with her on his Better Together podcast to discuss the notion of ideas as gifts. 2022-06-0548 minPodcast – The Race to Value Podcast™Podcast – The Race to Value Podcast™Ep 109 – Effective COPD Management to Achieve Value-Based Care Goals, with Dr. MeiLan Han Healthcare costs due to Chronic Obstructive Pulmonary Disease (COPD) is in excess of $32 billion due to high rates of re-hospitalizations and ED visits, complex and inefficient clinical pathways during transitions of care, and intensive resource burden on clinical and administrative staff. The average cost per COPD patient readmission in the U.S. typically falls between $9,000 and $12,000. Unlike other high cost chronic conditions like CHF and diabetes, it seems that many ACOs are not as purposeful in their targeting of COPD as part of their population health playbook. This is a massive unmet need with many COPD patients...2022-05-3158 minThe Race to Value PodcastThe Race to Value PodcastEp 109 – Effective COPD Management to Achieve Value-Based Care Goals, with Dr. MeiLan Han Healthcare costs due to Chronic Obstructive Pulmonary Disease (COPD) is in excess of $32 billion due to high rates of re-hospitalizations and ED visits, complex and inefficient clinical pathways during transitions of care, and intensive resource burden on clinical and administrative staff. The average cost per COPD patient readmission in the U.S. typically falls between $9,000 and $12,000. Unlike other high cost chronic conditions like CHF and diabetes, it seems that many ACOs are not as purposeful in their targeting of COPD as part of their population health playbook. This is a massive unmet need with many COPD patients...2022-05-3158 minEp 109 – Effective COPD Management to Achieve Value-Based Care Goals, with Dr. MeiLan Han Healthcare costs due to Chronic Obstructive Pulmonary Disease (COPD) is in excess of $32 billion due to high rates of re-hospitalizations and ED visits, complex and inefficient clinical pathways during transitions of care, and intensive resource burden on clinical and administrative staff. The average cost per COPD patient readmission in the U.S. typically falls between $9,000 and $12,000. Unlike other high cost chronic conditions like CHF and diabetes, it seems that many ACOs are not as purposeful in their targeting of COPD as part of their population health playbook. This is a massive unmet need with many COPD patients...2022-05-3158 minThe Doctor Dads PodcastThe Doctor Dads PodcastEpisode #116- BREATHING LESSONS- A Doctor’s Guide To Lung HealthDr. Nick and Dr. David interview Dr. MeiLan Han about our lung health and the impact that our respiratory health plays in our overall vitality. We discuss: - Three common misconception about our lungs - Simple and inexpensive testing to measure your lung health - Advancements that have been made since the pandemic - 3 most common lung diseases and how we can avoid them - COPD and lower respiratory diseases being the third and fourth leading cause of death globally - and more.... ...2022-05-2259 minDer AtemcodeDer AtemcodeBreathing Lessons - Lungengesundheit aus Sicht einer ÄrztinGemeinsam mit dem Sportpsychologen Nils Gatzmaga bespreche ich heute folgendes Buch: Breathing Lessons - A Doctor's Guide to Lung Health von Meilan K. Han In diesm Buch nimmt die führende Pneumologin und nationale Sprecherin der American Lung Association, Dr. Meilan K. Han, die Leser mit auf eine faszinierende Tour durch dieses vernachlässigte, aber wichtige Organ. Han erklärt das Wunder des Atmens und zeigt, wie die Lunge als erste Verteidigungslinie des Körpers dient. ###### Der Atemcodeclub! Gehe direkt zur Anmeldeseite Im Clubbereich gibt es jetzt auch...2022-05-1638 minHealth LabHealth LabCOVID Recovery and Lung HealthWe have expanded the Michigan Medicine News Break to include Twitter Space conversations with Michigan Medicine experts. Today's episode is a conversation about COVID and overall lung health shared by three experts from the Division of Pulmonary and Critical Care Medicine. COVID-19 has affected all of us in some way, and unfortunately doesn't seem to be going anywhere anytime soon. Dr. MeiLan Han, Chief of the Division of Pulmonary and Critical Care Medicine at University of Michigan Health, Dr. Hallie Prescott and Dr. Thomas Valley, also of the Division of Pulmonary and Critical Care Medicine, dive into what the...2022-05-1334 minThe Emergency DocsThe Emergency DocsEp. 58 Breathing Easy With Dr. MeiLan HanPrioritize your health because you can’t function well and fulfill your roles if it is deteriorating. This episode features Dr. MeiLan Han, a pulmonary and critical care specialist, and the author of Breathing Lessons: A Doctor's Guide to Lung Health. Dr. Han will talk about why the lungs are so neglected and how we can all work on improving our own lung health. She will talk about COVID-19, the science behind masks, and exactly what a ventilator does. She also discusses what we can all do to be better lung health advocates for ourselves and our communities. You wi...2022-05-0444 minATS Breathe EasyATS Breathe EasyInterviewing for Your First Job in the Virtual EraGuests  Dr. MeiLan HanUniversity of MichiganDr. Mitchell GraysonOhio State UniversityDr. Başak ÇoruhUniversity of WashingtonHosts Dr. Vickram TejwaniCleveland Clinic Dr. Lauren EggertStanford University2022-05-0354 minWithin Normal Limits: Navigating Medical RisksWithin Normal Limits: Navigating Medical RisksA Discussion with Dr. MeiLan Han—A Leading Pulmonologist and AuthorThis special episode features Dr. MeiLan Han, a Professor of Medicine and Chief of Pulmonary and Critical Care at the University of Michigan and author of the book Breathing Lessons: A Doctor’s Guide to Lung Health. Dr. Han shares her perspective on the impact of COVID-related respiratory issues and how this emphasized the importance of healthy lungs and the vital role they play. She talks about her background in pulmonary care and why her desire to better educate patients (and other physicians) on lung health led to writing Breathing Lessons. The discussion also touches on research data insights, me...2022-04-2652 minMastering Medical DeviceMastering Medical DeviceWhat a Pulmonologist Wants You to Know About Your Lungs with Dr. Meilan HanSend us a textMeilan Han, MD is a Professor of Medicine and Chief of the Division of Pulmonary and Critical Care at the University of Michigan, and a spokesperson for the American Lung Association. She is the author of a recently released book, “Breathing Lessons, A Doctor’s Guide to Lung Health.” In this episode Dr. Han describes how the lungs function, what can go wrong with them, lung development and why we need to pay attention to how we treat our lungs during their development phases, what medical devices she uses, her advice for companies develo...2022-04-131h 00The Independent Physician\'s Blueprint: Ditch Corporate Controls To Reduce Medical Practice Burnout & Generate Wealth Beyond Residency TrainingThe Independent Physician's Blueprint: Ditch Corporate Controls To Reduce Medical Practice Burnout & Generate Wealth Beyond Residency Training028 - Breathing Through Life Powerfully To Reduce Burnout As A Physician with Dr. MeiLan Han, MDIn this episode, Coach JPMD interviews one of America’s most prominent Pulmonologists, Dr. MeiLan Han, MD on the importance of pulmonary health, interpersonal awareness, while she promotes her new book “Breathing Lessons: A Doctor’s Guide to Lung Health”. Dr MeiLan Han, MD MS, is a Professor of Medicine in the Division of Pulmonary and Critical Care at the University of Michigan. Originally from Idaho, Dr. Han received her medical degree from the University of Washington in Seattle, WA. She completed her residency in Internal Medicine and fellowship in Pulmonary and Critical Care Medicine at the Universit...2022-04-0727 minPodcasts360Podcasts360COPD: Women Leaders in Medicine, Ep. 14In this episode, Dr Singh interviews Meilan Han, MD, MS, University of Michigan (Ann Arbor, MI) and Jean Wright, MD, MBA, formerly Atrium Health (Charlotte, NC) on the management of COPD, including recent updates to COPD treatment guidelines, increasing public awareness, and diagnosing the disease early.2022-03-1640 minTown Hall Seattle Science SeriesTown Hall Seattle Science Series165. Dr. MeiLan K. Han with Dr. Albert Rizzo: A Doctor’s Guide to Lung HealthOn average, a person takes around 20,000 breaths each day; yet most of us never notice the rhythmic rush of air flowing in and out, keeping our bodies oxygenated and alive. And as many asthma or respiratory distress sufferers will attest, you don’t want to notice. But things are happening all around us that threaten our blissful ignorance of breathing — wildfire smoke, indoor and outdoor pollution, and Viruses like COVID-19, to name a few — and they will continue to impact us unless we take action. In her new book, Breathing Lessons: A Doctor’s Guide to Lung Health, lea...2022-01-2554 minRare Care PodcastRare Care PodcastAn Interview With MeiLan K. Han, MD, MS, chief of the University of Michigan’s Division of Pulmonary & Critical Care. Larry Luxner, senior correspondent for Rare Disease Advisor, interviews MeiLan K. Han, MD, chief of the University of Michigan’s Division of Pulmonary & Critical Care in Ann Arbor. Dr. Han, a spokeswoman for the American Lung Association, leads groundbreaking research on oxygen delivery in chronic lung disease and has also written a book on the subject.2022-01-2113 minPri-Med News & Industry FeaturesPri-Med News & Industry FeaturesIdentifying Patients for De-escalation or Withdrawal of Inhaled Corticosteroids (ICS) in COPDGuests: MeiLan Han, MD, MS & Barbara P Yawn, MD, MSc, FAAFP For more information, please visit https://www.pri-med.com/podcast/clinical-practice-recommendations-ics  2021-12-2009 minPri-Med News & Industry FeaturesPri-Med News & Industry FeaturesThe Global Initiative For Chronic Obstructive Lung Disease (GOLD) 2021 Report – Takeaways for Healthcare PractitionersGuests: MeiLan Han, MD, MS & Barbara P Yawn, MD, MSc, FAAFP For more information, please visit https://www.pri-med.com/podcast/clinical-practice-recommendations-copd-gold  2021-12-2013 minManaged Care CastManaged Care CastA Pulmonologist on Why You Should Think About Respiratory Health and the LungsCOVID-19’s effects on the body are now known to be far-reaching—and long-lasting in the most severe cases—but when it started spreading across the world in early 2020, initial attention was focused on the lungs. That concern led to worries about the impact of infection for individuals with respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma. On this episode of Managed Care Cast, we speak with Meilan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the l...2021-11-1617 minFULL FRAMEFULL FRAMEFull Frame 128 / PABLO CHACÓN / FESTIVAL VEINTINUEVE TRECE LANZAROTEEl fotógrafo, editor y profesor Pablo Chacón (Valencia, 1976) protagoniza hoy una nueva emisión de Full Frame. Chacón, colaborador habitual de medios como XLSemanal o el Diari Ara, es un fotógrafo documental que, entre otros proyectos, ha trabajado el objeto como la encarnación de la huella que han dejado personas fusiladas durante la represión posterior a la Guerra Civil en Paterna (Valencia) -"Un acto de amor"-, personas que optaron por el suicidio evocadas a través de los utensilios que usaron para ejecutarlo -"Colapso"- o los objetos plásticos hallados en el est...2021-11-0256 minEmbrace Your Day With A Immersive Full Audiobook.Embrace Your Day With A Immersive Full Audiobook.Breathing Lessons: A Doctor's Guide to Lung Health by Meilan K. HanPlease visithttps://thebookvoice.com/podcasts/1/audiobook/527294to listen full audiobooks. Title: Breathing Lessons: A Doctor's Guide to Lung Health Author: Meilan K. Han Narrator: Meilan K. Han Format: Unabridged Audiobook Length: 4 hours 30 minutes Release date: November 2, 2021 Genres: Medicine & Naturopathy Publisher's Summary: An authoritative, accessible guide to how our lungs work and how to protect them. Most of us pay little attention to the workings of our lungs, but the COVID-19 pandemic has sparked interest in their functioning and fear about the risks they face. Dr. MeiLan K. Han, a leading pulmonologist and a national spokesperson for the American Lung Association...2021-11-024h 30Press Play On The Sensational Full Audiobook Now, Curious Minds!Press Play On The Sensational Full Audiobook Now, Curious Minds!Breathing Lessons: A Doctor's Guide to Lung Health by Meilan K. HanPlease visithttps://thebookvoice.com/podcasts/1/audiobook/527294to listen full audiobooks. Title: Breathing Lessons: A Doctor's Guide to Lung Health Author: Meilan K. Han Narrator: Meilan K. Han Format: Unabridged Audiobook Length: 4 hours 30 minutes Release date: November 2, 2021 Genres: Disorders & Diseases Publisher's Summary: An authoritative, accessible guide to how our lungs work and how to protect them. Most of us pay little attention to the workings of our lungs, but the COVID-19 pandemic has sparked interest in their functioning and fear about the risks they face. Dr. MeiLan K. Han, a leading pulmonologist and a national spokesperson for the American Lung Association...2021-11-024h 30Get Top Full Audiobooks in Health & Wellness, Disorders & DiseasesGet Top Full Audiobooks in Health & Wellness, Disorders & DiseasesBreathing Lessons: A Doctor's Guide to Lung Health by Meilan K. HanPlease visithttps://thebookvoice.com/podcasts/1/audiobook/527294to listen full audiobooks. Title: Breathing Lessons: A Doctor's Guide to Lung Health Author: Meilan K. Han Narrator: Meilan K. Han Format: Unabridged Audiobook Length: 4 hours 30 minutes Release date: November 2, 2021 Genres: Disorders & Diseases Publisher's Summary: An authoritative, accessible guide to how our lungs work and how to protect them. Most of us pay little attention to the workings of our lungs, but the COVID-19 pandemic has sparked interest in their functioning and fear about the risks they face. Dr. MeiLan K. Han, a leading pulmonologist and a national spokesperson for the American Lung Association...2021-11-024h 30EndoGeniusEndoGeniusProtect Your Lungs for Life | Dr. MeiLan HanHelp support this podcast by subscribing on Apple Podcasts, leaving a 5-star review, and sharing with your friends and family!We need your suggestions! Let us know what you like and dislike about the show, give us suggestions for future topics and guests! Your feedback will help shape the podcast!So many of us take breathing – a vital bodily function – for granted because it happens on an unconscious level. So much so that we're oblivious to how our lungs work or what factors could potentially put us at risk. Lung cancer is the leadi...2021-10-261h 00LungcastLungcastCOPD Check-In with Dr. MeiLan HanOur last episode of 2020 caps advances and ongoing research into the most burdensome chronic respiratory disease in the US.2020-12-0736 minuh-PARENT-lyuh-PARENT-lyuh-PARENT-ly | The vaping epidemic: what to look for, why it’s dangerous and how to get helpA federal study released by the Centers for Disease Control shows 27.5 percent of high school students have used e-cigarettes in the past 30 days. Now the CDC, the U.S. Food and Drug Administration, and state and local health departments are investigating a multistate outbreak of lung disease associated with e-cigarette use. uh-PARENT-ly cohosts Anne Johnsos and Tracy Weiner talk to Dr. MeiLan K. Han, professor of internal medicine in the Division of Pulmonary and Critical Care Medicine at the University of Michigan Health System and spokesperson for the American Lung Association, about the dangers of vaping and how parents...2019-09-1900 minListen to The Lancet Respiratory MedicineListen to The Lancet Respiratory MedicineCOPD care delivery in the USA: The Lancet Respiratory Medicine: May 13, 2016MeiLan Han discusses the highlights of the Commission with Luke Worley.2016-05-1410 minThe Lancet Respiratory Medicine in conversation withThe Lancet Respiratory Medicine in conversation withCOPD care delivery in the USA: The Lancet Respiratory Medicine: May 13, 2016MeiLan Han discusses the highlights of the Commission with Luke Worley.Continue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv2016-05-1410 min